Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.
Paysign, Inc. reports developments in patient affordability programs, donor compensation solutions, engagement and management platforms, and integrated payment processing for the life sciences industries. The company operates at the intersection of fintech and healthcare, serving plasma, pharmaceutical and life sciences customers with payment and program-management technologies.
Recurring updates cover earnings results, patient affordability growth, pharmaceutical copay program performance, claims-processing activity, plasma donor compensation revenue, and SaaS engagement technologies for donor and program management. Company announcements also discuss Dynamic Business Rules for mitigating copay accumulators and maximizers, physical, virtual, mobile and bank-based payment capabilities, reporting and analytics, and investor conference participation.
Paysign, Inc. (NASDAQ: PAYS) reported its third quarter 2020 financial results, showing a 32% revenue decline year-over-year, primarily due to COVID-19's impact on the pharma and plasma industries. Total revenues fell to $16.87 million, with a net loss of $4.83 million, down from a profit of $5.57 million in 2019. Operating expenses surged 39% due to staffing and professional service costs. Despite these challenges, the company remains optimistic about recovery as new client onboarding may boost revenues in the fourth quarter.
Paysign, Inc. (NASDAQ: PAYS) will discuss its 2020 Q3 earnings on November 17, 2020, at 5:00 p.m. ET. The financial results, including the Form 10-Q, will be released after market close. Investors can participate via a U.S. dial-in at 877.407.2988 or internationally at 201.389.0923. A replay of the call will be available using the conference ID 13713279.
Paysign is known for its prepaid card programs and integrated payment services across various sectors, including healthcare and retail, aimed at improving operational efficiency and customer loyalty.